Skip to main content
. 2021 Nov 8;13(11):1893. doi: 10.3390/pharmaceutics13111893

Table 2.

Antioxidant status and HDAC6-inhibiting ability of hydroxamic acids with a natural origin CAP group.

% of Activity * IC50 HDAC6 Inhibitory Activity, µM
Inhibition of LPO Antiradical Activity
t-BHP Fe (II)
Trolox 99.11 ± 3.72 97.21 ± 4.09 - -
Trich. A - - - 0.03 ± 0.01
1 - - - -
2 - - 32.02 ± 3.33 -
11 35.96 ± 1.99 28.39 ±7.41 22.22 ± 1.40 0.69 ± 0.02
12 30.36 ± 1.98 44.02 ± 1.57 - 4.06 ± 0.48
13 24.02 ± 3.44 28.90 ± 3.38 - 9.44 ± 0.74
14 22.62 ± 4.31 37.91 ± 1.08 - 4.48 ± 0.13
15 43.24 ± 1.28 21.52 ± 2.15 19.70 ± 1.34 0.96 ± 0.01
16 16.27 ± 0.42 26.41 ± 2.58 - 0.74 ± 0.01
23 18.26 ± 4.90 32.91 ± 1.12 20.14 ± 1.28 18.03 ± 1.02
24 20.63 ± 3.92 34.16 ± 1.37 20.32 ± 0.41 4.06 ± 0.39
25 44.59 ± 1.73 19.81 ± 4.83 43.34 ± 1.42 6.52 ± 0.40

The data in the table are presented as mean ± SEM. The ‘-’ mark indicates the lack of activity of the test substances (≤10%) in a particular test. *—under the action of substances at a 100 μM concentration.